ZION:NASDAQZions Bancorporation N.A. Analysis

Zions Bancorporation posted a Q1 earnings beat, with revenue up 10% year‑over‑year and GAAP EPS of $1.56, comfortably above consensus estimates. The bank’s trailing P/E of ~9.4 is well below the industry average of ~16.5, underscoring a clear valuation discount. A dividend yield near 3% combined with a modest 27% payout ratio suggests the dividend is well‑covered by earnings and cash reserves. The discounted cash‑flow model values the shares at roughly $136, implying an upside of over 13% versus the current price of $60.8. Operating margins of 36% and a ROE of 14% indicate strong profitability for a regional bank. Technically, the stock sits above its 50‑day (≈$59) and 200‑day (≈$57) SMAs, confirming a bullish trend, while the 20‑day SMA (~$62.5) provides a near‑term resistance point. RSI at 46 signals a neutral stance, and the MACD histogram is modestly negative, hinting at short‑term pressure. Support around $60.6 aligns closely with today’s price, offering a floor for investors. The beta of 1.31 and 30‑day volatility of 24% reflect higher market sensitivity, but volume remains stable. Recent news of an earnings beat and an upcoming ex‑dividend date are positive catalysts, though a March investigation by a law firm adds a layer of regulatory uncertainty. Overall, the blend of strong fundamentals, attractive valuation, and dividend income makes ZION a compelling buy for medium‑ to long‑term horizons.
Given the modest short‑term technical weakness and the pending legal scrutiny, a cautious stance is advisable now, with a view to add positions on any pull‑back toward the support level. The upside potential, defensive dividend, and undervalued status outweigh the elevated beta and sector‑specific risks, supporting a buy recommendation for investors with a medium to long horizon.